Export indicator metadata as an Excel file See Indicator Results: View indicator results as an interactive web page (opens in a new window) or download indicator results as a PDF

Indicator Metadata

Name

Percentage of Claims Accepted by Public Drug Programs for Generic Drugs

Short/Other Names

Not applicable

Description

The rate of claims accepted by public drug programs for generic drugs

Interpretation

This indicator is interpreted as the proportion of utilization that generic drug products account for within public drug programs.

HSP Framework Dimension

Health System Inputs and Characteristics: Efficient allocation of resources

Areas of Need

Not applicable

Geographic Coverage

Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nova Scotia, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon

Reporting Level/Disaggregation

Province/Territory

Indicator Results

https://secure.cihi.ca/estore/productSeries.htm?locale=en&pc=PCC1011

Identifying Information
Name

Percentage of Claims Accepted by Public Drug Programs for Generic Drugs

Short/Other Names

Not applicable

Indicator Description and Calculation
Description

The rate of claims accepted by public drug programs for generic drugs

Calculation: Description

The total number of claims accepted by public drug programs for generic drugs divided by the total number of claims accepted by public drug programs

Unit of Analysis: Claims to public drug programs

Calculation: Geographic Assignment

Place of residence

Calculation: Type of Measurement

Percentage or proportion

Calculation: Adjustment Applied

None

Calculation: Method of Adjustment

Not applicable

Denominator

Description:
Total number of claims made to public drug programs

Inclusions:
All claims accepted by public drug programs

Exclusions:
Any claims not submitted to or accepted by public drug programs, including claims submitted to a private insurer or cases where the individual pays out of pocket

Numerator

Description:
Total number of claims made to public drug programs for a generic drug product
Inclusions:
All claims for generic drugs accepted by public drug programs

Exclusions:

  1. Any claims not submitted to or accepted by public drug programs, including claims submitted to a private insurer or cases where the individual pays out of pocket
  2. Claims for brand name products
Background, Interpretation and Benchmarks
Rationale This indicator measures the uptake of generic drugs on public drug programs. Generic drug products are typically less expensive than brand name products.
Interpretation This indicator is interpreted as the proportion of utilization that generic drug products account for within public drug programs.
HSP Framework Dimension Health System Inputs and Characteristics: Efficient allocation of resources
Areas of Need Not applicable
Targets/Benchmarks Not applicable
References Not applicable
Availability of Data Sources and Results
Data Sources NPDUIS Database
Available Data Years Type of Year:
Calendar
First Available Year:
2000
Last Available Year:
2019
Geographic Coverage Newfoundland and Labrador, Prince Edward Island, New Brunswick, Nova Scotia, Quebec, Ontario, Manitoba, Saskatchewan, Alberta, British Columbia, Yukon
Reporting Level/Disaggregation Province/Territory
Result Updates
Update Frequency Whenever required for analytical product or data request
Indicator Results Web Tool:
Prescribed Drug Spending in Canada
URL: https://secure.cihi.ca/estore/productSeries.htm?locale=en&pc=PCC1011
Updates Not applicable
Quality Statement
Caveats and Limitations
  • Includes only drugs claimed through public drug programs
  • Excludes any drugs claimed through a private drug plan or purchased over the counter
Trending Issues All data is not available for all years:
  • Manitoba, Saskatchewan, Alberta, New Brunswick: From January 2000
  • Nova Scotia: From April 2001
  • Prince Edward Island: From April 2004
  • British Columbia: From January 2006
  • Yukon: From January 2007
  • Newfoundland and Labrador: From April 2008
  • Ontario: From April 2010
  • First Nations and Inuit Health Branch: From October 2010
Comments Not applicable